EWA LLC’s AstraZeneca AZN Stock Holding History

EWA LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$520K	Buy	2,740 +1,097	+67%	+$206K	0.09%	131
2026 Q1	$324K	Buy	+1,643	New	+$317K	0.07%	160

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EWA LLC's AZN Position: Q2 2026 in Review

EWA LLC increased its AstraZeneca (AZN) stake by 67% in Q2 2026, buying an estimated $206K and bringing the position to 2,740 shares worth $520K. The position accounts for 0.09% of the portfolio, ranked #131.

EWA LLC first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

EWA LLC held 2,740 shares of AstraZeneca worth $520K as of Q2 2026.
EWA LLC bought 1,097 AstraZeneca shares in Q2 2026, an estimated $206K.
AstraZeneca made up 0.09% of EWA LLC's portfolio in Q2 2026, its #131 holding.
EWA LLC first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.